Back to All Events

Prevalence of AAV2.5 Neutralizing Antibodies in Synovial Fluid and Serum of Patients with Osteoarthritis

  • Live Webinar United States (map)

Course Description:

Osteoarthritis is the number one cause of disability in the elderly with limited management options and no curative options. This presentation will describe the role of IL-1 in osteoarthritis and how to identify the implications of anti-AAV neutralizing antibodies in AAV gene therapy. By gaining knowledge of this topic healthcare providers may offer hope of better treatment options in the future.

 

 

 

Course Link:
https://educationacademy.maryfreebed.com/#/public-dashboard
CE Value (credits): 1
CE Type: Standard

Sponsor:
Mary Free Bed Rehabilitation Hospital

Contact Information:
Bonita Pawloski
616-840-8292
bonita.pawloski@maryfreebed.com